Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
Paul Thompson MD
Paul D. Thompson MD Advisory Board
James Udelson MD
James E. Udelson MD Advisory Board
See All Experts
featured
Published in Cardiology

Journal Scan / Research · August 06, 2020

Cardiovascular and Bleeding Risks Associated With NSAID Treatment After Myocardial Infarction

Journal of the American College of Cardiology

 

 Save  Recommend
 Share

Additional Info

Journal of the American College of Cardiology
Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction
J Am Coll Cardiol 2020 Aug 04;76(5)518-529, DO Kang, H An, GU Park, Y Yum, EJ Park, Y Park, WY Jang, W Kim, JY Choi, SY Roh, JO Na, JW Kim, EJ Kim, SW Rha, CG Park, HS Seo, CU Choi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated